As a manufacturer of the disinfectant NEMESIS eH2O, Adrian Gee-Turner explains why it is necessary to read a disinfectant’s label in order to determine whether it is suitable for the intended application.
Any one of us can walk in to a supermarket and purchase a disinfectant/sanitiser in the confident belief that this product will protect us and our family. However, there are a number of important issues that should be taken into consideration. For example, is that product effective on the target microorganisms? And how quickly does it kill them?
Typically, an anti-bacterial sanitiser will offer 99.9% kill of bacteria including Salmonella, Listeria, Influenza and E.Coli. However, the main concern at the moment is of course COVID-19, a virus, so an anti-bacterial sanitiser is not necessarily suited for this purpose.
There are of course disinfectants that have proven efficacy against viruses, but in assessing that efficacy it is important to note the contact time required – how long does the product have to be in contact with the virus before it is deactivated? This is important because extended contact times in laboratory tests are not practical in real world situations.
During a viral pandemic, it is important that appropriate surfaces are disinfected with products that quickly and effectively deactivate all of the main problematic pathogens including viruses. This means that all surfaces that are regularly touched should be disinfected, with sufficient contact time. NEMESIS eH2O has been tested and shown to deactivate a broad spectrum of pathogens within seconds – this includes Viruses, Influenza, E. Coli, S. Aureus, Norovirus, MRSA, Protozoa and C. Difficile. These tests have shown the ability of Nemesis eH2O to kill 99.9999% of harmful micro-organisms on contact.
The %age kill for a disinfectant is another vitally important consideration. The difference between 99.9% and 99.9999% may not seem like much, but in fact it means, for example, that Nemesis eH2O is 1,000 times more effective than a disinfectant claiming 99.9%. This is because Logarithmic reduction is the standard used for quantifying disinfection. For example, healthcare disinfection may require a ≥6-log reduction of test organisms, Staphylococcus aureus, and Pseudomonas aeruginosa in ≤10 minutes. So, a 1-log reduction in colony forming units (CFUs) represents a 90% reduction and 2-log represents a 99% reduction, and so on. 6-log reduction therefore represents a reduction of CFUs by 99.9999%. To put this in perspective, a typical supermarket sanitiser with 99.9% efficacy (3-log) could be expected (in the right conditions) to reduce a colony of 1 million CFUs to 1,000 CFUs – microorganisms capable reproducing quickly. In contrast, a 6-log sanitiser (such as NEMESIS eH2O) would reduce the same size colony down to just one CFU – a dramatic and very significant difference. The lower the efficacy; the greater the need for repeated treatment.
In addition to the disinfection of surfaces that are regularly touched, it is also necessary to disinfect hands – hence the requirement for frequent hand washing. Alternatively, or in addition, alcohol-based hand antiseptics containing ethanol, isopropanol or n-propanol, or a combination thereof can be employed. According to the World Health Organisation, the main advantages of alcohol-based hand sanitisers are that they are fast-acting and broad-spectrum. Also, in a healthcare setting they can overcome the limited availability of taps and washbasins.
Alcohol solutions containing 60–80% alcohol are most effective, with higher concentrations being less potent. Alcohols have excellent in vitro germicidal activity against Gram-positive and Gram-negative vegetative bacteria and a variety of fungi. However, they have virtually no activity against bacterial spores or protozoan oocysts, and very poor activity against some non-enveloped (non-lipophilic) viruses.
Frequent use of alcohol-based formulations for hand antisepsis tends to cause drying of the skin unless humectants or other skin conditioning agents are added to the formulations. However, even well-tolerated alcohol-based handrubs containing humectants may cause a transient stinging sensation at the site of any broken skin. Alcohols are also flammable so appropriate safety precautions are necessary.
A major advantage of NEMESIS eH2O, is that is it pH neutral and in addition to surfaces it can also be applied to skin; even sensitive skin, and with no alcohol it does not cause any damage or cracking of the skin after frequent use.
As outlined above there a number of important issues to be considered when choosing a disinfectant:
NEMESIS eH2O performs extremely well in such a detailed assessment of disinfectant labels, and as such represents the ideal solution for disinfection in a wide range of applications including health care, domestic use, food processing and animal housing.
Sterling Presentation Health was founded in 2015 with a focus on the importance of infection prevention. Working with ground-breaking scientists, the founders developed Nemesis eH2O; a natural antiseptic, anti-bacterial, antiviral and antifungal disinfectant.
Nemesis eH2O technology mimics the human immune system; utilising hypochlorous acid (HOCl) to combat viruses, bacteria and other pathogenic microorganisms. The unique process by which Nemesis eH2O is manufactured requires just salt, water and electrolysis. Developed over 12 years, the Nemesis scientists have established a process that delivers a stable form of hypochlorous acid (pH neutral/very weak acid) with a 12 month shelf-life.
Nemesis eH2O is certified as one of the most powerful disinfectants on the market, but remarkably it is environmentally benign; it has no harmful chemicals, no waste product, no preservatives, no colour, no alcohol and no allergic reaction. As a result, Nemesis eH2O can be used as a sanitiser on any surface including sensitive human skin.
Tested and certified as a biocide for the world’s most dangerous diseases, Nemesis eH2O kills 99.9999% of harmful micro-organisms on contact. This includes Viruses, Influenza, E. coli, S. aureus, Norovirus, MRSA and C. difficile.